- Home
- WFRD vs PBH Comparison
WFRD vs PBH Comparison
Compare WFRD & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFRD
- PBH
- Stock Information
- Founded
- WFRD 1941
- PBH 1996
- Country
- WFRD United States
- PBH United States
- Employees
- WFRD N/A
- PBH N/A
- Industry
- WFRD Metal Fabrications
- PBH Biotechnology: Pharmaceutical Preparations
- Sector
- WFRD Industrials
- PBH Health Care
- Exchange
- WFRD Nasdaq
- PBH Nasdaq
- Market Cap
- WFRD 4.2B
- PBH 3.9B
- IPO Year
- WFRD N/A
- PBH 2005
- Fundamental
- Price
- WFRD $57.62
- PBH $76.32
- Analyst Decision
- WFRD Strong Buy
- PBH Buy
- Analyst Count
- WFRD 7
- PBH 5
- Target Price
- WFRD $96.00
- PBH $94.00
- AVG Volume (30 Days)
- WFRD 1.2M
- PBH 449.4K
- Earning Date
- WFRD 07-22-2025
- PBH 08-07-2025
- Dividend Yield
- WFRD 1.73%
- PBH N/A
- EPS Growth
- WFRD N/A
- PBH 2.88
- EPS
- WFRD 6.50
- PBH 4.29
- Revenue
- WFRD $5,147,000,000.00
- PBH $1,137,762,000.00
- Revenue This Year
- WFRD N/A
- PBH $2.04
- Revenue Next Year
- WFRD $2.72
- PBH $2.07
- P/E Ratio
- WFRD $8.91
- PBH $17.84
- Revenue Growth
- WFRD N/A
- PBH 1.10
- 52 Week Low
- WFRD $36.74
- PBH $64.94
- 52 Week High
- WFRD $128.43
- PBH $90.04
- Technical
- Relative Strength Index (RSI)
- WFRD 61.74
- PBH 33.73
- Support Level
- WFRD $52.33
- PBH $75.14
- Resistance Level
- WFRD $59.60
- PBH $77.45
- Average True Range (ATR)
- WFRD 2.42
- PBH 1.33
- MACD
- WFRD 0.13
- PBH 0.16
- Stochastic Oscillator
- WFRD 73.11
- PBH 35.02
About WFRD Weatherford International plc
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.